Bisphenol A effects on gene expression in adipocytes from children: Association with metabolic disorders

Journal of Molecular Endocrinology

Volumn 54, Issue 3, 2015, Pages 289-303

  Menale, Ciro ^a,b,f   Piccolo, Maria Teresa ^a,b,c   Cirillo, Grazia ^a   Calogero, Raffaele A ^d   Papparella, Alfonso ^a   Mita, Luigi ^b,e   Del Giudice, Emanuele Miraglia ^a   Diano, Nadia ^a,b   Crispi, Stefania ^b,c   Mita, Damiano Gustavo ^b,e  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b NATIONAL INSTITUTE OF BIOSTRUCTURES AND BIOSYSTEMS   (Italy)

^c CNR   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

^e INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

^f HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

Adipocytes; Bisphenol A; Children; Gene expression; Metabolic homeostasis

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; CD36 ANTIGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGEN RELATED RECEPTOR GAMMA; FATTY ACID BINDING PROTEIN 4; G PROTEIN COUPLED RECEPTOR 30; INSULIN; INTERLEUKIN 18; INTERLEUKIN 1BETA; LEPTIN; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 4; SUBTILISIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; BENZHYDRYL DERIVATIVE; ENDOCRINE DISRUPTOR; ESTRADIOL; PHENOL DERIVATIVE; TRANSCRIPTOME;

ADIPOCYTE; ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CELL STRUCTURE; CHEMICAL MODIFICATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DEREGULATION; DISEASE ASSOCIATION; DOWN REGULATION; ENDOCRINE FUNCTION; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INFLAMMATION; LIPID METABOLISM; LIPID STORAGE; MALE; METABOLIC DISORDER; METABOLIC REGULATION; MICROARRAY ANALYSIS; ORCHIDOPEXY; PANCREAS CELL; PREPUBERTY; PRIORITY JOURNAL; PROADIPOCYTE; SCHOOL CHILD; TRANSCRIPTION REGULATION; UPREGULATION; BIOSYNTHESIS; CELL CULTURE; DRUG EFFECTS; METABOLISM; PATHOLOGY; SECRETION (PROCESS);

ADIPOCYTES; BENZHYDRYL COMPOUNDS; CELLS, CULTURED; CHILD; ENDOCRINE DISRUPTORS; ESTRADIOL; FEMALE; HUMANS; INSULIN; LIPID METABOLISM; MALE; METABOLIC DISEASES; PHENOLS; TRANSCRIPTOME;

EID: 84953709659     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-14-0282     Document Type: Article

References (70)

1. Alonso-Magdalena P, Vieira E, Soriano S, Menes L, Burks D, Quesada I & Nadal A 2010 Bisphenol A exposure during pregnancy disrupts glucose homeostasis in mothers and adult male offspring. Environmental Health Perspectives 118 1243-1250. (doi:10. 1289/ehp. 1001993)
2. Alonso-Magdalena P, Ropero AB, Soriano S, Garcia-Arevalo M, Ripoll C, Fuentes E, Quesada I & Nadal A 2012 Bisphenol-A acts as a potent estrogen via non-classical estrogen triggered pathways. Molecular and Cellular Endocrinology 355 201-207. (doi:10. 1016/j. mce. 2011. 12. 012)
3. Angle BM, Do RP, Ponzi D, Stahlhut RW, Drury BE, Nagel SC, Welshons WV, Besch-Williford CL, Palanza P, Parmigiani S et al. 2013 Metabolic disruption inmalemice due to fetal exposure to low but not high doses of bisphenol A (BPA): evidence for effects on body weight, food intake, adipocytes, leptin, adiponectin, insulin and glucose regulation. Reproductive Toxicology 42 256-268. (doi:10. 1016/j. reprotox. 2013. 07. 017)
4. Banerjee M & Saxena M 2012 Interleukin-1 (IL-1) family of cytokines: role in type 2 diabetes. Clinica Chimica Acta 413 1163-1170. (doi:10. 1016/j. cca. 2012. 03. 021)
5. Bhandari R, Xiao J & Shankar A 2013 Urinary bisphenol A and obesity in U. S. children. American Journal of Epidemiology 177 1263-1270. (doi:10. 1093/aje/kws391)
6. Boucher JG, Boudreau A & Atlas E 2014 Bisphenol A induces differentiation of human preadipocytes in the absence of glucocorticoid and is inhibited by an estrogen-receptor antagonist. Nutrition & Diabetes 4 e102. (doi:10. 1038/nutd. 2013. 43)
7. Brennan AM & Mantzoros CS 2006 Drug Insight: the role of leptin in human physiology and pathophysiology-emerging clinical applications. Nature Clinical Practice. Endocrinology & Metabolism 2 318-327. (doi:10. 1038/ncpendmet0196)
8. Creemers JW, Choquet H, Stijnen P, Vatin V, Pigeyre M, Beckers S, Meulemans S, Than ME, Yengo L, Tauber M et al. 2012 Heterozygous mutations causing partial prohormone convertase 1 deficiency contribute to human obesity. Diabetes 61 383-390. (doi:10. 2337/ db11-0305)
9. Crispi S 2013 Transcriptional profiling of endometriosis tissues identifies genes related to organogenesis defects. Journal of Cellular Physiology 228 1927-1934. (doi:10. 1002/jcp. 24358)
10. Crispi S, Calogero RA, Santini M, Mellone P, Vincenzi B, Citro G, Vicidomini G, Fasano S, Meccariello R, Cobellis G et al. 2009 Global gene expression profiling of human pleural mesotheliomas: identification of matrix metalloproteinase 14 (MMP-14) as potential tumour target. PLoS One 4 e7016. (doi:10. 1371/journal. pone. 0007016)
11. Delclos KB, Camacho L, Lewis SM, Vanlandingham MM, Latendresse JR, Olson GR, Davis KJ, Patton RE, Gamboa da Costa G, Woodling KA et al. 2014 Toxicity evaluation of bisphenol A administered by gavage to Sprague Dawley rats from gestation day 6 through postnatal day 90. Toxicological Sciences 139 174-197. (doi:10. 1093/toxsci/kfu022). ?
12. Duffaut C, Zakaroff-Girard A, Bourlier V, Decaunes P, Maumus M, Chiotasso P, Sengenes C, Lafontan M, Galitzky J & Bouloumie A 2009 Interplay between human adipocytes and T lymphocytes in obesity CCL20 as an adipochemokine and T lymphocytes as lipogenic modulators. Arteriosclerosis, Thrombosis, and Vascular Biology 29 1608-1614. (doi:10. 1161/ATVBAHA. 109. 192583)
13. Endemann G, Stanton LW, Madden KS, Bryant CM, White RT & Protter AA 1993 CD36 is a receptor for oxidized low density lipoprotein. Journal of Biological Chemistry 268 11811-11816.
14. Eng DS, Lee JM, Gebremariam A, Meeker JD, Peterson K & Padmanabhan V 2013 Bisphenol A and chronic disease risk factors in US children. Pediatrics 132 e637-e645. (doi:10. 1542/peds. 2013-0106)
15. Esser N, L'Homme L, De Roover A, Kohnen L, Scheen AJ, Moutschen M, Piette J, Legrand-Poels S & Paquot N 2013 Obesity phenotype is related to NLRP3 inflammasome activity and immunological profile of visceral adipose tissue. Diabetologia 56 2487-2497. (doi:10. 1007/ s00125-013-3023-9)
16. Ford J, Hajibeigi A, Long M, Hahner L, Gore C, Hsieh JT, Clegg D, Zerwekh J & Oz OK 2011 GPR30 deficiency causes increased bone mass, mineralization, and growth plate proliferative activity in male mice. Journal of Bone and Mineral Research 26 298-307. (doi:10. 1002/ jbmr. 209)
17. Fried SK, Ricci MR, Russell CD & Laferrere B 2000 Regulation of leptin production in humans. Journal of Nutrition 130 3127S-3131S.
18. Giguere V 2008 Transcriptional control of energy homeostasis by the estrogen-related receptors. Endocrine Reviews 29 677-696. (doi:10. 1210/ er. 2008-0017)
19. Hajri T, Han XX, Bonen A & Abumrad NA 2002 Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null mice. Journal of Clinical Investigation 109 1381-1389. (doi:10. 1172/JCI0214596)
20. Halden RU 2010 Plastics and health risks. Annual Review of Public Health 31179-194. (doi:10. 1146/annurev. publhealth. 012809. 103714)
21. Hamil L, Benghuzzi H & Tucci M 2008 Evaluation of insulin secretion by pancreatic cells in response to increasing amounts of glucose. Biomedical Sciences Instrumentation 44 441-446.
22. Hardaway AL & Podgorski I 2013 IL-1β, RAGE and FABP4: targeting the dynamic trio in metabolic inflammation and related pathologies. Future Medicinal Chemistry 5 1089-1108. (doi:10. 4155/fmc. 13. 90)
23. Harley KG, Aguilar Schall R, Chevrier J, Tyler K, Aguirre H, Bradman A, Holland NT, Lustig RH, Calafat AM & Eskenazi B 2013 Prenatal and postnatal bisphenol A exposure and body mass index in childhood in the CHAMACOS cohort. Environmental Health Perspectives 121 514-520, 520e511-516. (doi:10. 1289/ehp. 1306866)
24. Hashimoto I, Wada J, Hida A, Baba M, Miyatake N, Eguchi J, Shikata K & Makino H 2006 Elevated serum monocyte chemoattractant protein-4 and chronic inflammation in overweight subjects. Obesity 14 799-811. (doi:10. 1038/oby. 2006. 93)
25. Hugo ER, Brandebourg TD, Woo JG, Loftus J, Alexander JW & Ben-Jonathan N 2008 Bisphenol A at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytes. Environmental Health Perspectives 116 1642-1647. (doi:10. 1289/ehp. 11537)
26. Iyer A, Fairlie DP, Prins JB, Hammock BD & Brown L 2010 Inflammatory lipid mediators in adipocyte function and obesity. Nature Reviews. Endocrinology 6 71-82. (doi:10. 1038/nrendo. 2009. 264)
27. Jackson RS, Creemers JW, Ohagi S, Raffin-Sanson ML, Sanders L, Montague CT, Hutton JC & O'Rahilly S 1997 Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nature Genetics 16 303-306. (doi:10. 1038/ng0797-303)
28. Kang JH, Kondo F & Katayama Y 2006 Human exposure to bisphenol A. Toxicology 226 79-89. (doi:10. 1016/j. tox. 2006. 06. 009)
29. Kuri-Harcuch W & Green H 1978 Adipose conversion of 3T3 cells depends on a serum factor. PNAS 75 6107-6109. (doi:10. 1073/pnas. 75. 12. 6107)
30. Lakind JS, Goodman M & Mattison DR 2014 Bisphenol A and indicators of obesity, glucosemetabolism/type 2 diabetes and cardiovascular disease: a systematic review of epidemiologic research. Critical Reviews in Toxicology 44 121-150. (doi:10. 3109/10408444. 2013. 860075)
31. Lee HA, Kim YJ, Lee H, Gwak HS, Park EA, Cho SJ, Kim HS, Ha EH & Park H 2013 Effect of urinary bisphenol a on androgenic hormones and insulin resistance in preadolescent girls: a pilot study from the Ewha birth & growth cohort. International Journal of Environmental Research and Public Health 10 5737-5749. (doi:10. 3390/ijerph10115737)
32. Li Y, Burns KA, Arao Y, Luh CJ & Korach KS 2012 Differential estrogenic actions of endocrine-disrupting chemicals bisphenol A, bisphenol AF, and zearalenone through estrogen receptor α and β in vitro. Environmental Health Perspectives 120 1029-1035. (doi:10. 1289/ehp. 1104689)
33. Liang Q, Gao X, Chen Y, Hong K & Wang HS 2014 Cellular mechanism of the nonmonotonic dose response of bisphenol A in rat cardiac myocytes. Environmental Health Perspectives 122 601-608.
34. Lin Y, Sun X, Qiu L, Wei J, Huang Q, Fang C, Ye T, Kang M, Shen H & Dong S 2013 Exposure to bisphenol A induces dysfunction of insulin secretion and apoptosis through the damage of mitochondria in rat insulinoma (INS-1) cells. Cell Death & Disease 4 e460. (doi:10. 1038/ cddis. 2012. 206)
35. Liu X, Matsushima A, Okada H, Tokunaga T, Isozaki K & Shimohigashi Y 2007 Receptor binding characteristics of the endocrine disruptor bisphenol A for the human nuclear estrogen-related receptor γ. Chief and corroborative hydrogen bonds of the bisphenol A phenol-hydroxyl group with Arg316 and Glu275 residues. FEBS Journal 274 6340-6351. (doi:10. 1111/j. 1742-4658. 2007. 06152. x)
36. Martensson UE, Salehi SA, Windahl S, Gomez MF, Sward K, Daszkiewicz-Nilsson J, Wendt A, Andersson N, Hellstrand P, Grande PO et al. 2009 Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates estradiol-stimulated insulin release in female mice. Endocrinology 150 687-698. (doi:10. 1210/en. 2008-0623)
37. Martin MG, Lindberg I, Solorzano-Vargas RS, Wang J, Avitzur Y, Bandsma R, Sokollik C, Lawrence S, Pickett LA, Chen Z et al. 2013 Congenital proprotein convertase 1/3 deficiency causes malabsorptive diarrhea and other endocrinopathies in a pediatric cohort. Gastroenterology 145 138-148. (doi:10. 1053/j. gastro. 2013. 03. 048)
38. Masuno H, Kidani T, Sekiya K, Sakayama K, Shiosaka T, Yamamoto H & Honda K 2002 Bisphenol A in combination with insulin can accelerate the conversion of 3T3-L1 fibroblasts to adipocytes. Journal of Lipid Research 43 676-684.
39. Masuno H, Iwanami J, Kidani T, Sakayama K & Honda K 2005 Bisphenol a accelerates terminal differentiation of 3T3-L1 cells into adipocytes through the phosphatidylinositol 3-kinase pathway. Toxicological Sciences 84 319-327. (doi:10. 1093/toxsci/kfi088)
40. Nicolucci C, Rossi S, Menale C, del Giudice EM, Perrone L, Gallo P, Mita DG & Diano N 2013 A high selective and sensitive liquid chromatographytandem mass spectrometry method for quantization of BPA urinary levels in children. Analytical and Bioanalytical Chemistry 405 9139-9148. (doi:10. 1007/s00216-013-7342-y)
41. Odegaard JI, Ricardo-Gonzalez RR, Goforth MH, Morel CR, Subramanian V, Mukundan L, Red Eagle A, Vats D, Brombacher F, Ferrante AW et al. 2007 Macrophage-specific PPARγ controls alternative activation and improves insulin resistance. Nature 447 1116-1120. (doi:10. 1038/ nature05894)
42. Ohlstein J, Strong AL, McLachlan JA, Gimble JM, Burow ME & Bunnell BA 2014 Bisphenol A enhances adipogenic differentiation of human adipose stromal/stem cells. Journal of Molecular Endocrinology 53345-353. (doi:10. 1530/JME-14-0052)
43. Okada H, Tokunaga T, Liu X, Takayanagi S, Matsushima A&Shimohigashi Y 2008 Direct evidence revealing structural elements essential for the high binding ability of bisphenol A to human estrogen-related receptor-γ. Environmental Health Perspectives 116 32-38. (doi:10. 1289/ ehp. 10587)
44. Ouchi N, Parker JL, Lugus JJ & Walsh K 2011 Adipokines in inflammation and metabolic disease. Nature Reviews. Immunology 11 85-97. (doi:10. 1038/nri2921)
45. Owyang AM, Maedler K, Gross L, Yin J, Esposito L, Shu L, Jadhav J, Domsgen E, Bergemann J, Lee S et al. 2010 XOMA 052, an anti-IL-1β monoclonal antibody, improves glucose control and β-cell function in the diet-induced obesity mouse model. Endocrinology 151 2515-2527. (doi:10. 1210/en. 2009-1124)
46. Pravenec M, Landa V, Zidek V, Musilova A, Kazdova I, Qi N, Wang J, St Lezin E & Kurtz TW 2003 Transgenic expression of CD36 in the spontaneously hypertensive rat is associated with amelioration of metabolic disturbances but has no effect on hypertension. Physiological Research 52 681-688.
47. Rac ME, Safranow K & PoncyljuszW2007 Molecular basis of human CD36 gene mutations. Molecular Medicine 13 288-296. (doi:10. 2119/2006-00088. Rac)
48. Rochester JR 2013 Bisphenol A and human health: a review of the literature. Reproductive Toxicology 42 132-155. (doi:10. 1016/j. reprotox. 2013. 08. 008)
49. Sakurai K, Kawazuma M, Adachi T, Harigaya T, Saito Y, Hashimoto N & Mori C 2004 Bisphenol A affects glucose transport in mouse 3T3-F442A adipocytes. British Journal of Pharmacology 141 209-214. (doi:10. 1038/ sj. bjp. 0705520)
50. Samaras K, Botelho NK, Chisholm DJ & Lord RV 2010 Subcutaneous and visceral adipose tissue gene expression of serum adipokines that predict type 2 diabetes. Obesity 18 884-889. (doi:10. 1038/oby. 2009. 443)
51. Sharma G, Hu CL, Brigman JL, Zhu G, Hathaway HJ & Prossnitz ER 2013 GPER deficiency in male mice results in insulin resistance, dyslipidemia, and a proinflammatory state. Endocrinology 154 4136-4145. (doi:10. 1210/en. 2013-1357)
52. Singh S & Li SS 2012 Bisphenol A and phthalates exhibit similar toxicogenomics and health effects. Gene 494 85-91. (doi:10. 1016/ j. gene. 2011. 11. 035)
53. Smyth GK 2004 Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Statistical Applications in Genetics and Molecular Biology 3 1-25. (doi:10. 2202/1544-6115. 1027)
54. Tack CJ, Stienstra R, Joosten LA & Netea MG 2012 Inflammation links excess fat to insulin resistance: the role of the interleukin-1 family. Immunological Reviews 249 239-252. (doi:10. 1111/j. 1600-065X. 2012. 01145. x)
55. Takayanagi S, Tokunaga T, LiuX, Okada H, Matsushima A&Shimohigashi Y 2006 Endocrine disruptor bisphenol A strongly binds to human estrogen-related receptor gamma (ERRγ) with high constitutive activity. Toxicology Letters 167 95-105. (doi:10. 1016/j. toxlet. 2006. 08. 012)
56. Thomas P & Dong J 2006 Binding and activation of the seventransmembrane estrogen receptor GPR30 by environmental estrogens: a potential novel mechanism of endocrine disruption. Journal of Steroid Biochemistry and Molecular Biology 102 175-179. (doi:10. 1016/j. jsbmb. 2006. 09. 017)
57. Tohme M, Prud'homme SM, Boulahtouf A, Samarut E, Brunet F, Bernard L, Bourguet W, Gibert Y, Balaguer P & Laudet V 2014 Estrogen-related receptor γ is an in vivo receptor of bisphenol A. FASEB Journal 28 3124-3133. (doi:10. 1096/fj. 13-240465)
58. Trasande L, Attina TM & Blustein J 2012 Association between urinary bisphenol A concentration and obesity prevalence in children and adolescents. Journal of American Medical Association 308 1113-1121. (doi:10. 1001/2012. jama. 11461)
59. Turpeinen H, Ortutay Z & Pesu M 2013 Genetics of the first seven proprotein convertase enzymes in health and disease. Current Genomics 14 453-467. (doi:10. 2174/1389202911314050010)
60. Valentino R, D'Esposito V, Passaretti F, Liotti A, Cabaro S, Longo M, Perruolo G, Oriente F, Beguinot F & Formisano P 2013 Bisphenol-A impairs insulin action and up-regulates inflammatory pathways in human subcutaneous adipocytes and 3T3-L1 cells. PLoS ONE 8 e82099. (doi:10. 1371/journal. pone. 0082099)
61. Vandenberg LN 2014 Non-monotonic dose responses in studies of endocrine disrupting chemicals: bisphenol a as a case study. Dose-Response 12 259-276. (doi:10. 2203/dose-response. 13-020)
62. Villaret A, Galitzky J, Decaunes P, Esteve D, Marques MA, Sengenes C, Chiotasso P, Tchkonia T, Lafontan M, Kirkland JL et al. 2010 Adipose tissue endothelial cells from obese human subjects: differences among depots in angiogenic, metabolic, and inflammatory gene expression and cellular senescence. Diabetes 59 2755-2763. (doi:10. 2337/db10-0398)
63. Vom Saal FS, Nagel SC, Coe BL, Angle BM & Taylor JA 2012 The estrogenic endocrine disrupting chemical bisphenol A (BPA) and obesity. Molecular and Cellular Endocrinology 354 74-84. (doi:10. 1016/j. mce. 2012. 01. 001)
64. Wang J, Sun B, Hou M, Pan X & Li X 2013 The environmental obesogen bisphenol A promotes adipogenesis by increasing the amount of 11β-hydroxysteroid dehydrogenase type 1 in the adipose tissue of children. International Journal of Obesity 37 999-1005. (doi:10. 1038/ ijo. 2012. 173)
65. Wei J, Lin Y, Li Y, Ying C, Chen J, Song L, Zhou Z, Lv Z, Xia W, Chen X et al. 2011 Perinatal exposure to bisphenol A at reference dose predisposes offspring to metabolic syndrome in adult rats on a high-fat diet. Endocrinology 152 3049-3061. (doi:10. 1210/ en. 2011-0045)
66. Welshons WV, Nagel SC & vom Saal FS 2006 Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology 147 S56-S69. (doi:10. 1210/ en. 2005-1159)
67. WestfallPH&Young SS 1993 Resampling-Based Multiple Testing: Examples and Methods for p-Value Adjustment. New York, NY, USA: John Wiley & Sons.
68. Xu A, Tso AW, Cheung BM, Wang Y, Wat NM, Fong CH, Yeung DC, Janus ED, Sham PC & Lam KS 2007 Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study. Circulation 115 1537-1543. (doi:10. 1161/CIRCULATIONAHA. 106. 647503)
69. Yang R & Barouch LA 2007 Leptin signaling and obesity: cardiovascular consequences. Circulation Research 101 545-559. (doi:10. 1161/ CIRCRESAHA. 107. 156596)
70. Zha BS & Zhou H 2012 ER stress andlipidmetabolism inadipocytes. Biochemistry Research International 2012 312943. (doi:10. 1155/2012/312943)